Celldex May Have Best Efficacy In Chronic Spontaneous Urticaria

Sanofi Also Succeeds With BTKi In Phase II

 
• By Joseph Haas
  
Urticaria
Both Celldex and Sanofi hope to challenge Xolair in CSU • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D